Medtronic, Inc. (MDT) PT Raised to $87 at Oppenheimer Following 3Q Report
Tweet Send to a Friend
Oppenheimer raised its price target on Medtronic, Inc. (NYSE: MDT) to $87.00 (from $84.00) while maintaining a Outperform rating.Analyst Steven ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
